Cargando…

Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPARα Pathway

Lentinan (LNT), a type of polysaccharide derived from Lentinus edodes, has manifested protective effects during liver injury and hepatocellular carcinoma, but little is known about its effects on nonalcoholic fatty liver disease (NAFLD). This study aimed to investigate whether LNT can affect the pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Tingyi, Fang, Qin, Zhang, Zhihao, Zhu, Chuanmeng, Xu, Renfan, Chen, Guangzhi, Wang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780611/ https://www.ncbi.nlm.nih.gov/pubmed/35050176 http://dx.doi.org/10.3390/metabo12010055

Ejemplares similares

Soluble Epoxide Hydrolase Inhibition Protected against Diabetic Cardiomyopathy through Inducing Autophagy and Reducing Apoptosis Relying on Nrf2 Upregulation and Transcription Activation
por: Fang, Qin, et al.
Publicado: (2022)

Association Between Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) Polymorphisms and Nonalcoholic Fatty Liver Disease: A HuGE Review and Meta-Analysis
por: Xu, Renfan, et al.
Publicado: (2015)

Update on Pparγ and Nonalcoholic Fatty Liver Disease
por: Ables, Gene P.
Publicado: (2012)

Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPARα Signaling Pathway
por: Huang, Ping, et al.
Publicado: (2022)

Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease
por: Wang, Yun-liang, et al.
Publicado: (2015)

Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis †
por: Yamashita, Shizuya, et al.
Publicado: (2023)

Role of Apolipoprotein A1 in PPAR Signaling Pathway for Nonalcoholic Fatty Liver Disease
por: Chen, Changxi, et al.
Publicado: (2022)

Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis
por: Qiu, Han, et al.
Publicado: (2022)

Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease
por: Ding, Jiexia, et al.
Publicado: (2015)

Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling
por: Zhong, Jing, et al.
Publicado: (2023)

Melatonin alleviates cadmium-induced nonalcoholic fatty liver disease in ducks by alleviating autophagic flow arrest via PPAR-α and reducing oxidative stress
por: Sun, Jian, et al.
Publicado: (2023)

Protective Effects of Lentinan Against Lipopolysaccharide-Induced Mastitis in Mice
por: Yin, Huifang, et al.
Publicado: (2021)

Lentinan Supplementation Protects the Gut–Liver Axis and Prevents Steatohepatitis: The Role of Gut Microbiota Involved
por: Yang, Xiaoying, et al.
Publicado: (2022)

PPARα Ameliorates Doxorubicin-Induced Cardiotoxicity by Reducing Mitochondria-Dependent Apoptosis via Regulating MEOX1
por: Wang, Wei, et al.
Publicado: (2020)

Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
por: Yang, Jiayao, et al.
Publicado: (2020)

Palmitate-induced Regulation of PPARγ via PGC1α: a Mechanism for Lipid Accumulation in the Liver in Nonalcoholic Fatty Liver Disease
por: Maruyama, Hitoshi, et al.
Publicado: (2016)

Lentinan protects pancreatic β cells from STZ‐induced damage
por: Zhang, Yaqin, et al.
Publicado: (2016)

The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE(−/−)FXR(−/−) Mice
por: Lee, Yenna, et al.
Publicado: (2021)

Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases
por: Ina, Kenji, et al.
Publicado: (2016)

Lentinan dose dependence between immunoprophylaxis and promotion of the murine liver cancer
por: Wang, Ying, et al.
Publicado: (2017)

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
por: Montagner, Alexandra, et al.
Publicado: (2016)

The Use of Lentinan for Treating Gastric Cancer
por: Ina, Kenji, et al.
Publicado: (2013)

Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity
por: Videla, Luis A., et al.
Publicado: (2012)

Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions
por: Lee, Yong-Jik, et al.
Publicado: (2017)

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
por: Kumar, Divya P., et al.
Publicado: (2020)

Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPARδ-AMPK-PGC-1α Pathway in Dyslipidemic Conditions
por: Han, Yoon-Mi, et al.
Publicado: (2020)

Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer
por: Jiang, Qin, et al.
Publicado: (2021)

Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease
por: Kamata, Shotaro, et al.
Publicado: (2023)

PPARα activation protects against cholestatic liver injury
por: Zhao, Qi, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Protective effect of whey proteins against nonalcoholic fatty liver in rats
por: Hamad, Essam M, et al.
Publicado: (2011)

Protective role of arnebin-1 in rats with nonalcoholic fatty liver disease
por: Yang, Weijia, et al.
Publicado: (2019)

The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2021)

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
por: Zhao, ChenLu, et al.
Publicado: (2023)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021)

Regulation Studies of Telomerase Gene in Cancer Cells by Lentinan
por: Sreenivasulu, Kamma, et al.
Publicado: (2010)

Oridonin improves the therapeutic effect of lentinan on lung cancer
por: Gui, Yun, et al.
Publicado: (2021)

Reduced Glutathione suppresses Oxidative Stress in Nonalcoholic Fatty Liver Disease
por: Irie, Makoto, et al.
Publicado: (2016)

Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils
por: Xu, Haiyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rp6k4f35se6f9r22c2kdcjosfa